JOIN NOW

Why not join CURE today?
Individual memberships welcome!

Good for bioscience in Connecticut. Good for you.
JOIN NOW

The CURE Calendar


Jan
25
Wed
Business of Biotech @ Alexion Pharmaceuticals
Jan 25 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Jan
27
Fri
Building International Bridges in the Life Sciences: Hungary, Poland and the BioForum of Central Europe @ Quinnipiac University North Haven Campus - School of Law, Courtroom 100
Jan 27 @ 8:30 am – 4:00 pm
Connecticut companies are invited to meet potential collaborators in Hungary and Poland at this one-day forum exploring opportunities in the life sciences markets of Central Europe.
RSVP by January 20
Feb
15
Wed
Business of Biotech @ Alexion Pharmaceuticals
Feb 15 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Mar
27
Mon
CURE at Saint Joseph University Featuring: Susan Baserga – Resilience and Ribosomes: Practicing Persistence in Life and in the Lab @ University of Saint Joseph - Crystal Room, Mercy Hall, First floor.
Mar 27 @ 4:00 pm – 6:00 pm

Host:

Susan Froshauer, Ph.D., President & CEO of CURE, President of CURE Innovations, LLC.

Susan is an experienced scientist, mentor, entrepreneur and angel investor with skill at connecting academic expertise and technology with the commercial sector. Susan is involved with the Yale Entrepreneurial Institute, the CTNEXT funded group, SECT Tech, the Creative Arts Workshop and the Angel Investor Forum. Prior to joining CURE, Dr. Froshauer was Director of the Technology Exchange Portal at the University of Connecticut’s Office of Economic Development. In this role Susan assisted Connecticut-based entrepreneurs and organizations with initiatives that train students, create jobs and contribute to economic development. She connected ideas with business expertise, business plans with investors and industry with scholars. Her passion and commitment is helping bioscience entrepreneurs build successful companies.

Speakers:

 

Susan Baserga, MD, Ph.D., Professor of Molecular Biophysics and Biochemistry, of Genetics and Therapeutic Radiology, Yale University

Susan Baserga received a B.S. in Biology from Yale College and an M.D. and Ph.D. (Human Genetics) from Yale in 1988.  She conducted post-doctoral training in the Department of Molecular Biophysics and Biochemistry at Yale with Joan Steitz.  Susan is currently an Associate Professor at Yale University with a primary appointment in Molecular Biophysics & Biochemistry and joint appointments in the Departments of Genetics and Therapeutic Radiology.  The focus of Susan’s research is on the function of ribonucleoproteins in pre-rRNA processing and pre-ribosome assembly.  Her research is principally funded by the National Institutes of Health and the National Science Foundation.

 

Melissa Marcucci, Ph.D., Associate Professor and Chair, Department of Biology, USJ

Serving as a tenured faculty member and Chair in the biology department at the University of Saint Joseph (USJ), Dr. Marcucci has provided students with a wide range of necessary tools to succeed in biology-based professions and STEM graduate programs.  She has shared her knowledge of biology in the classroom in a teaching and advisory capacity, as well as in the research laboratory.  Until becoming Chair, Dr. Marcucci maintained a research affiliation in the department of internal medicine at Yale University where she studied the molecular defects of insulin signaling in type 2 diabetes.  Dr. Marcucci also served as the Director of the CREC Summer Institutes for Science and Math for three summer, a collaboration with the Capitol Regions Education Council, to offer summer residence programs at USJ to select area high school students demonstrating academic excellence in STEM fields.  Currently, Dr. Marcucci currently serves as the Chair of the department of biology at USJ, a large complex department that is active in research and has a strong curriculum preparing students for professional careers in biomedical research, medicine, pharmaceutical sciences, and industry.  Aside from her passion for the biological sciences, Dr. Marcucci also advocates for leadership opportunities for women in science.

Directions and Parking:

 

Informational map showing the buildings and the exact location of talk on USJ campus: http://www.usj.edu/files/9514/7005/6952/campus_map.pdf

 

Refer to above map for parking at USJ:  best locations for parking are the large lots adjacent to the Center for Applied Research and Education (CARE) Building (#18 on map), visitors spots behind Mercy Hall (#1), and the large lot behind the Pope Pius XII Library (#12) (note that the numbers correspond to locations on the map)

 

Driving directions to USJ:  http://www.usj.edu/about-us/maps-directions/driving-direct/

 

SPONSORS:

    

 

 

Apr
19
Wed
Business of Biotech @ Alexion Pharmaceuticals
Apr 19 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Serial Entrepreneur: David Scheer

Biotech Entrepreneur Kevin Rakin:
The Business of Science

A CT Bioscience Entrepreneur’s
Story: Craig M. Crews, Ph.D.

video-icon-Crews-200px

Partner Videos

Yale Video “Innovation to Impact: Dr. Lieping Chen and NextCure”

video-icon-nextcure2016-200x113px

Talent Wanted/Talent Available

> Connecticut BioScience Job Listings
> BioScience Résumés

Click Here

Bioscience ClubhouseCT and Career Ladder Grant

Applications now being accepted. Get the details.
Click Here